After several doctors voiced concerns about the poor quality of domestically produced generic medications included in China’s national health-care plan—and after online sleuths found numerous examples ...

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...

In his first 24 hours in office, President Donald Trump unleashed a series of executive orders. These 22 orders, ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Here's a roundup of consumer alerts you should know about today:>> Kia vehiclesThe company says some of their cars have ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

If you had a machine that was manufacturing bullets in the commonwealth and you sold them, you couldn’t do that legally," a ...

The ASX closed flat as Chinese AI disruptor DeepSeek spooked Nasdaq, tanked Nvidia and infected local tech stocks.

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

One such drug, fentanyl – a synthetic opioid that’s 50 to 100 times more potent than morphine – is the leading reason U.S. overdose deaths have surged in recent years. While the rate of fentanyl ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...